Skip to content

Respond to Grant Reviewer Comments: NIH A1 Guide

Updated 8 official sources

Quick Answer: When resubmitting a federal grant, you must include an introduction page, including 1 page for NIH A1 applications, that directly addresses each reviewer critique from your summary statement.

Full answer and how we checked it

Use 6 steps: repeated critique, score-driving weakness, feasibility gap, single-reviewer concern, not-implemented suggestion, and new-data update. Resubmissions are most likely to improve when they show concrete changes to methodology, address feasibility concerns with preliminary data, and acknowledge valid criticisms without being defensive.

Data note: Review and resubmission rules reflect NIH, CSR, NSF, and Grants.gov source checks completed on June 17, 2026. Agency rules may shift by NOFO, activity code, and submission cycle.

Source review by Grantsights, June 3, 2026: We checked the NIH Application Guide, NIH Grants Policy Statement resubmission rules, NIH peer-review framework materials, NSF PAPPG, and agency resubmission practices against this guide. Where official sources stop: federal pages state the rules, but they do not tell applicants how to triage critique severity under the current review framework. Based on our analysis, a bad fit is using the 1-page NIH introduction to rebut every minor comment instead of leading with changes that move Importance or Rigor and Feasibility. For example, an A0 with a power-calculation weakness should spend the first response on the revised sample size and analysis plan, not on reviewer wording.

In this guide

If you're a principal investigator or grant writer preparing a resubmission after a rejection, this guide shows you how to address reviewer critiques effectively.

Knowing how to respond to grant reviewer comments is one of the most practically important skills in academic research funding. NIH gives you 1 page. The decisions you make about what to address, how to say it, and what to leave out determine whether your resubmission scores better, worse, or the same.

This guide walks through the strategic framework for responding to reviewer comments across different federal funding mechanisms, with specific rules for NIH, NSF, and community-based agencies.

June 17 Reviewer Comment Response Triage

According to NIH, a resubmission is an unfunded application that has been changed after initial review, and NIH accepts only 1 A1 resubmission for an original A0 application. According to CSR, the PI must receive the summary statement before submitting the A1, and overlapping aims cannot be under review at the same time. According to NIH's simplified review framework, most research project grants with due dates on or after January 25, 2025 are reviewed under 3 scored factors instead of the old 5-criterion structure. According to NSF's PAPPG, no revisions after declination are considered with the original proposal, and NSF may return a proposal that is substantially the same as one already reviewed and declined. According to Grants.gov, applicants must still follow the active opportunity package rather than treating a prior review as permission to submit outside the current instructions.

Use this order before writing the response. It keeps the 1-page NIH introduction focused on the comments most likely to move the score.

Reviewer signalFirst actionBad-fit response
Same weakness appears in 2 or 3 critiquesMake it the first response theme and show the exact revised sectionAnswering it only once in passing
Factor 1 concern under NIH simplified reviewLead with importance, rigor, feasibility, and the changed research planSpending space on reputation, biosketch, or environment defense
Feasibility, power, recruitment, or data gapAdd new data, a smaller scope, a revised analysis plan, or a stronger milestoneSaying the reviewer misunderstood without changing the plan
Single-reviewer minor wording issueFix in the narrative and mention only if space remainsGiving it equal space with score-driving weaknesses
NSF declined proposalMake a substantially revised new proposal and show the major changes in the project narrativeResubmitting a near-copy and expecting the old reviews to carry over
Program officer discourages resubmissionAsk whether a new A0, different NOFO, or narrower route is cleanerForcing an A1 because the team already wrote one

The Grantsights rule is simple: do not respond to comments in chronological order. Respond in score-risk order. A good A1 introduction reads like a change map, not a rebuttal memo. Use this guide with how to read your NIH summary statement, how to resubmit an NIH grant, NIH paylines explained, and the grant search hub when you need to compare reviewer risk with current funding routes.


The Core Principle: Acknowledge, Don't Argue

Before anything else, this is the mindset that separates effective resubmissions from ineffective ones.

Your goal isn't to prove that a reviewer was wrong. Your goal is to get funded.

Even when a reviewer clearly misread your application, even when the concern reflects a gap in their domain expertise, and even when you can demonstrate that the application already addressed the concern - the right response is not to argue. The right response is to acknowledge that the original application wasn't clear enough to prevent the misreading, clarify what you meant, show how you've revised it, and move on.

Reviewers on the resubmission panel may not be the same people who reviewed the original application. Your introduction needs to make sense to someone reading your application for the first time. Defending against the original reviewers' comments in a way that assumes the new reviewers already know what those comments were will confuse your response and waste your limited space.


NIH-Specific Rules: The 1-Page Introduction

NIH allows 1 page or less, unless the funding opportunity says otherwise, at the start of a resubmission (A1 application) called the "Introduction to Revised Application." For official guidance on resubmission formatting, see the NIH Application Guide (opens in a new tab). Here's what you need to know about how to use it.

It's the only place you address reviewer comments directly. Don't scatter responses to critiques throughout the revised research strategy. The introduction is where you respond; the research strategy is where you show the revisions.

The introduction precedes the research strategy in your application. Reviewers see it before they read your revised science. That means it also functions as a roadmap to your revisions.

Point reviewers to where the changes are. Every substantive response should include a pointer to the relevant section of the revised research strategy. "We have revised Aim 2 to incorporate a 3-month feasibility phase (Research Strategy, pages 5-6)" is better than "We have addressed this concern."

Don't use the introduction to repeat your science. You have the Research Strategy for that (12 pages for an R01, 6 for an R21 or R03). The introduction is for acknowledging concerns and directing reviewers to your responses.


Response StrategyWhen to UseReviewer Impact
Direct address with dataReviewer questioned your evidenceHigh: shows rigor
Added co-investigatorReviewer flagged expertise gapHigh: addresses capacity concern
Additional preliminary dataReviewer questioned feasibilityHigh: demonstrates progress
Rewritten methodologyReviewer found design flawsMedium-High: shows responsiveness
Scope reductionReviewer said "overly ambitious"Medium: shows realism
Rebuttal without changeReviewer misunderstood your approachLow: risks appearing defensive

NSF-Specific Rules

NSF doesn't use the formal A0/A1 resubmission structure that NIH does. There's no formal limit on resubmissions to NSF, but program officers can advise you not to resubmit - and if they do, you should take that seriously.

Some NSF programs allow a "Summary of Changes" section, but this varies by program and funding opportunity announcement. Always check the specific FOA for what's permitted.

For NSF resubmissions, your changes need to be evident in the proposal itself. There's no separate response letter required. When a program officer has given you informal feedback, incorporate that feedback substantively and don't reference the private conversation in your proposal.


SAMHSA, DOJ, and ED Rules

At SAMHSA, the Department of Justice, and the Department of Education, there's typically no formal resubmission process. When a competition closes and awards are made, unfunded applicants who want to try again must re-apply to the next competition as if they're submitting fresh.

Each new competition is evaluated independently, without reference to previous submissions. Reviewers in the next cycle won't see your prior application or any scores from it.

This means you can incorporate reviewer feedback from a prior cycle without formally labeling it as a "response." You don't need to acknowledge it as a revision - you can simply build a stronger proposal that addresses the weaknesses reviewers previously identified. Many successful applicants do exactly that.


The Structure of a Strong NIH Resubmission Introduction

Here's a reliable structure for the 1-page introduction. It won't work for every application, but it's a sound starting point.

Opening (1 to 2 sentences): State the major revisions made. This gives reviewers a map before they read the details. "In this revision, we have addressed the reviewers' concerns regarding the rigor of Aim 2 by adding 6 months of pilot data, strengthened the statistical power calculation, and added Dr. [Name] as a co-investigator providing expertise in [specific methodology]."

Point-by-point responses (most of the page): Address major concerns in order of importance, not in the order they appear in the summary statement. The concern that most affected your score goes first.

Each response follows the same basic pattern:

  1. Acknowledge the concern in 1 sentence
  2. Describe what you changed in 1 to 2 sentences
  3. Point to where it appears in the revised application

Close (1 to 2 sentences): Note any significant new developments since original submission - new data, new collaborators, new publications - that weren't available when you submitted the A0.


Prioritizing Which Concerns to Address

You can't address everything in 1 page. You have to make decisions about what belongs there.

Address first:

  • Major concerns flagged by multiple reviewers (these drove the score most directly)
  • Major concerns from a single reviewer that are methodologically valid even if not shared by all reviewers

Address second:

  • Weaknesses mentioned by 2 or more reviewers, even if each reviewer considered it minor individually. Convergence means the issue matters.

Address briefly or fold into revisions:

  • Single-reviewer minor concerns that were clearly secondary to the scoring discussion

What to do with suggestions you're not implementing: Don't ignore them. A brief sentence explaining why you didn't make a change is better than silence. "Reviewer 2 suggested expanding the sample to include [population]. We have considered this carefully, but doing so would require [specific resource] and would substantially change the scope of the study. We have addressed the underlying concern by [alternative approach]." This signals thoughtfulness rather than stubbornness.


From Manusights, our sister product

For an NIH resubmission, the hard part is ranking which concerns get space on a one-page Introduction.

Manusights offers an AI critique of NIH applications against NIH's review criteria. For a resubmission, you upload your summary statement and your application. Each critique is sorted into “the reviewers missed it”, “we were unclear” or “a real flaw”, and the fixes are ranked by the criterion each one moves. Writing a new F31, F32, R01 or R21? It critiques those before you submit, too.

It's critique only. It never writes any part of your application, gives no score, and doesn't predict whether you'll be funded. NIH has no part in it.

Order online: $49 for an F31 or F32, $149 for a new R01, R21 or K award application, $199 for a resubmission plan. Back within 3 business days of your upload.

Order a grant review

The Psychology of Reviewer Response

Reviewers have read hundreds of resubmission introductions. They know when applicants are being defensive, and defensiveness damages credibility.

Phrases that signal defensiveness:

  • "The reviewer misunderstood..."
  • "As clearly stated in the original application..."
  • "We respectfully disagree..."
  • "This concern reflects a misreading of..."

Phrases that work better:

  • "We recognize that our description of [X] was not sufficiently clear..."
  • "We have revised [section] to address this concern directly..."
  • "The reviewer's concern is valid, and we have strengthened [specific element] accordingly..."

Here's a concrete example. Suppose a reviewer wrote: "The PI has not provided adequate evidence that the proposed cell culture model is appropriate for this research question."

Defensive response (don't write this): "The reviewer misunderstood our model selection rationale. As described on page 7 of the original application, our cell culture model has been validated in 3 published studies, including Smith et al. (2023), which the reviewers apparently did not read carefully."

Effective response (write this instead): "We recognize that our justification for the cell culture model wasn't fully developed in the original application. We have added a dedicated subsection on model selection (Research Strategy, pages 6-7) that presents validation data from 3 published studies and a direct comparison with the alternative model suggested by the reviewer. This comparison shows [specific finding that supports your choice]."

The difference: the effective version acknowledges the applicant's responsibility for the confusion, shows what was done about it, and demonstrates the evidence without attacking the reviewer.


When Reviewers Disagree with Each Other

You'll occasionally find that Reviewer 1 considers your approach excellent and Reviewer 3 considers it fundamentally flawed. This is common. Don't take sides.

The right approach: acknowledge that different methodological approaches exist, explain why your approach is appropriate for your specific aims and context, and provide additional evidence supporting your choice.

If Reviewer 3's concern is methodologically valid, take it seriously even though Reviewer 1 didn't share it. In your introduction, you don't need to frame this as a disagreement between reviewers. Just address the substance: "We have strengthened the methodological rationale for [approach] in response to reviewer feedback, adding [specific evidence] in the Research Strategy (page 8)."


How to Flag Changes in the Revised Narrative

Your resubmission introduction points reviewers to changes throughout the narrative. Those changes should be findable quickly, but for NIH you can't mark them up in the narrative itself.

NIH's resubmission policy (opens in a new tab) says: "Do not markup changes within application attachments." That means no highlighting, coloring, bolding, or italicizing revised text in the Research Strategy, and no REVISED tags. A common mistake is carrying over a markup habit from a journal revision.

Point to changes from the introduction instead. Name the section, aim, and page where each substantive revision appears ("Research Strategy, Approach, Aim 2, page 6"). You don't need to point to minor wording edits. If you rewrote a full section to add new data and methodology, cite its location.

Every change you describe in the introduction should be findable in the revised narrative. If you say "we have added a feasibility study in Aim 2," the reviewer needs to be able to find that feasibility study in the research strategy.


When Not to Resubmit

Resubmission isn't always the right decision. There are situations where it's worth pausing and reconsidering.

Don't resubmit when:

  • Your application was triaged AND the critiques point to fundamental problems with the scientific approach, not just execution
  • The program officer tells you that the funding climate at this institute is tight and scores like yours weren't funded in recent rounds (NIH institutes stopped relying on paylines in January 2026, so the program officer's read matters more than a percentile)
  • The reviewers' central concerns reflect a genuine scientific limitation you can't actually fix within the scope of the resubmission (insufficient preliminary data for the scope of the project, for example)
  • Your career situation has changed significantly enough that the aims in the application no longer reflect your research direction
  • The grant program's priorities shifted and your project no longer fits

The NIH A0/A1 rule matters here: After an unsuccessful A1, you can't submit an A2. Per NIH's resubmission policy (opens in a new tab), you may submit the idea as a new application (A0). That's worth knowing before you submit an A1 that you're not sure is ready - because the A1 is your one formal resubmission opportunity.


Deciding Between Resubmission and a New Application

When an A1 is unsuccessful, some investigators find that a fresh perspective outperforms a heavily defended revision. A new A0 can restructure the aims, incorporate substantially new preliminary data, and approach the science from a different angle - rather than spending most of its introduction defending choices that two reviewer panels have now questioned.

Program officers can advise on this directly. Ask them: "Given the history of this application, would you recommend resubmission with revisions or a substantially new application?" It's a reasonable question and they'll give you an honest answer.

For a related discussion of how to interpret the feedback you're responding to, see How to Read Your NIH Summary Statement.


Timeline Considerations

According to NIH's standard due dates (opens in a new tab), new R01 applications are due February 5, June 5, and October 5, but R01 resubmissions, renewals, and revisions are due March 5, July 5, and November 5.

If your summary statement arrives in late October, the November 5 resubmission date is usually too close, and March 5 gives you about 4 months to substantially revise the application.

A workable plan for a strong resubmission usually needs at least 6 weeks:

  • 1 to 2 weeks to absorb the summary statement and make a resubmission plan
  • 2 to 3 weeks to generate new data, add new collaborators, and write the revisions
  • 1 to 2 weeks for internal review and institutional processing

Rushing a resubmission that isn't ready is worse than waiting one more cycle. A weak A1 closes off your formal resubmission pathway.

For a broader view of what happens after initial submission and before the resubmission decision, see What Happens After You Submit a Federal Grant.


The Scoring Shift NIH's New Review Framework Creates for Resubmission Introductions

For applications due on or after January 25, 2025, reviewers no longer score five separate criteria. They score two factors numerically: Importance of the Research (which consolidates Significance and Innovation) and Rigor and Feasibility (which consolidates Approach). The third factor, Expertise and Resources, is now a binary sufficient-or-not evaluation rather than a scored criterion. That structural change has real consequences for how you write your introduction page.

The old five-criterion structure meant that a reviewer who gave you a weak Innovation score could be offset by strong Significance, Investigator, and Environment scores. Under the new framework, those compensatory paths are narrower. A weak score on Rigor and Feasibility now weighs more heavily against your overall impact score because there are only two numerical factors. Reviewers may anchor more heavily on Approach problems when they exist, because there's no separate scored mechanism to compensate for a weak Approach. If your A0 summary statement flagged concerns about feasibility or methodology, your A1 introduction needs to address those specifically and show real changes, not just acknowledge the critique.

NIH's published data make the general point: resubmissions have historically been funded at higher rates than first submissions (see the NIH Data Book (opens in a new tab)), but a better A0 score gives an A1 more room to move. That matters because it tells you something about what a resubmission can realistically fix: if your A0 scored poorly because the science itself was underdeveloped, an introduction page can't fix that. The gap in the research strategy has to be real and visible, or the score won't move.

For a narrow Approach problem, an effective introduction can be four short paragraphs: one acknowledging the concern, one explaining the revised power calculation and sample size increase, one pointing reviewers to the updated methods section, and one briefly noting that the revised approach addresses the only substantive methodological critique. The point is to be surgical. A common mistake is trying to do too much in the one-page limit, addressing every reviewer comment, including the minor ones, rather than leading with the specific changes that move the score.

The shift to the Simplified Framework also changes how you should interpret a weak Importance score in your summary statement. Under the old criteria, weak Significance and weak Innovation were addressable separately. Under the new framework, if your Importance score is weak, you need to understand whether reviewers found the research question not compelling enough, the innovation insufficient, or both. Program officers can often help you parse this distinction, and that conversation is worth having before you draft your introduction.

What Federal Review Panel Guidelines Doesn't Tell You

Tone can hurt you as much as content. A defensive or dismissive resubmission cover letter can sink an otherwise strong revision. Start every response with what you changed, not why the reviewer was wrong.

Contradicting your own preliminary data is a red flag. If your initial submission included pilot results showing one outcome and your revision suddenly presents different numbers, reviewers will question data integrity. Explain any discrepancies explicitly.

Adding a new co-investigator to address a weakness works better than adding a consultant. Reviewers know consultants are often names on paper. A co-investigator with specific expertise and budgeted effort signals genuine capacity to address the gap.

Sources


FAQ: Common Questions

How long is the NIH resubmission introduction?

One page or less. NIH limits the Introduction to Revised Application to 1 page unless the funding opportunity specifies otherwise. It's placed at the beginning of the resubmission, before the research strategy, and it's the only section where you formally address reviewer comments. Don't assume you can go longer without that explicit permission.

Can I argue with reviewers in my NIH resubmission?

You shouldn't. Even when a reviewer's concern reflects a misreading, the effective response is to acknowledge that the original application wasn't clear enough to prevent the confusion, revise accordingly, and point reviewers to the change. Defensive or argumentative language damages your credibility with the new review panel, who may not have seen the original critique and won't appreciate the defensive framing.

What happens if my NIH A1 application is unsuccessful?

If your A1 doesn't get funded, you can't submit an A2 under current NIH policy. You may submit the idea as a new application (A0). NIH doesn't require the science to be substantively different (NOT-OD-18-197 (opens in a new tab)), but a new A0 can't include an Introduction responding to earlier critiques or mention previous reviewers' comments or scores, so it has to stand on its own rather than defend the previous 2 submissions. Some investigators choose to pivot to a different mechanism or a different institute if the A1 feedback suggests the project isn't a strong fit for the current study section.

Do I need to address every reviewer comment in my resubmission?

No. You have 1 page and you need to use it strategically. Address major concerns and weaknesses raised by multiple reviewers first. Single-reviewer minor concerns can be addressed briefly or folded into other revisions without explicit acknowledgment. Reviewers don't expect a point-by-point accounting of every minor comment - they expect to see that the most significant concerns were taken seriously and addressed substantively.

When should I decide not to resubmit a federal grant application?

Don't resubmit if the critiques identify fundamental scientific problems that can't be fixed within the scope of the application, if the program officer signals that the funding climate makes even a strong score unlikely to be funded, or if your career or scientific direction has changed substantially since submission. The resubmission process takes 3 to 6 months of significant effort. It's worth that effort only when you have a realistic path to a competitive score and a realistic funding environment.

Get research funding calls by email

About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.

No spam. Unsubscribe anytime.

Last updated October 10, 2026. Corrected October 10, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.